IBI3001

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3001, covering 2025-01-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors [Phase 1]